Osteoarthritis (OA) affects over 27 million Americans, causing an annual economic burden of over $300 million [1]. Left untreated, local cartilage defects promote cartilage degeneration and serve as a target for clinical and research based interventions [2]. While current treatments have limited success and result in recurring symptoms [3], tissue engineering solutions are promising for cartilage repair.

This content is only available via PDF.
You do not currently have access to this content.